The FDA-approved vaping cessation pill, varenicline, has emerged as a promising solution for teens and young adults struggling to break their vaping habits.Recent clinical trials conducted by researchers at Mass General Brigham have shown that this medication not only aids in quitting nicotine but also significantly boosts success rates among participants compared to traditional counseling alone.